BioPharma Dive June 6, 2024
The committee unanimously voted to recommend vaccine makers adapt their shots to cover a coronavirus lineage that’s more prevalent in the U.S. than the XBB variant previously targeted last year.
A group of advisers to the Food and Drug Administration on Wednesday unanimously recommended that COVID-19 vaccines be updated to cover coronavirus strains with a family known as JN.1 ahead of the fall.
The committee, which had originally been scheduled to meet in mid-May, supported targeting the JN.1 lineage broadly, rather than some specific subvariants that are now more prevalent in the U.S. Their recommendation matches the advice of the World Health Organization, which in April also recommended COVID shots cover the JN.1 family.
According to documents prepared by FDA...
Today's Sponsors
Today's Sponsor